Anzeige
Mehr »
Login
Dienstag, 26.10.2021 Börsentäglich über 12.000 News von 675 internationalen Medien
Heute im Fokus: InnoCan Pharma! Steht die nächste bahnbrechende News vor der Tür?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FierceBiotech

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
19:42Trice Medical nabs first FDA go-ahead for disposable arthroscope with 25-degree view
18:42Medable adds $304M to treasure chest with fourth raise in 18 months for virtual trials
17:42BD primes Amazon rollout of smartphone-based rapid COVID-19 test
16:42Eli Lilly, Bayer, Merck join Mozart's chorus to the tune of $55M, as it launches into allegro phase
15:42Lilly, Pfizer stop development of osteoarthritis drug after FDA rejection, extending bleak run for NGF inhibitors
14:42Eli Lilly kickstarts speedy FDA review for Alzheimer's hopeful donanemab-and a one-on-one test against Aduhelm
13:42Novartis dumps Rett gene therapy caught up in Zolgensma scandal in cull of pipeline prospects
13:42Flagship-founded Axcella to test midstage NASH drug in patients with long COVID in phase 2a trial
MoGuardant's liquid biopsy detects 96% of early-stage colorectal cancer cases with a single blood draw: study
MoIntellia, LogicBio fuel hope for in vivo gene editing with new animal data in rare diseases: report
MoBiden admin infuses $560M more to buttress COVID-19 testing supply chain
MoErytech shifts focus to leukemia as lead drug flunks late-stage pancreatic cancer trial
MoGilead's Immunomedics CMO jumps to Aadi as the biotech eagerly awaits FDA decision for first drug
MoRoche, Foundation Medicine start global launch of cancer genomic profiling kit for labs worldwide
MoJuventas Cell Therapy closes a $63M funding round as it eyes a big push for blood cancer hopeful
MoAstraZeneca veteran takes up CEO post at Medivir, becoming 4th person to hold the post in quick succession
MoEMA starts rolling review of Merck's molnupiravir, continuing rapid regulatory response to COVID-19 antiviral data
FrWith Sanofi still on board, Click Therapeutics closes $52M series B for digital therapeutics in depression, chronic pain and more
FrOcular's insert for dry eye disease misses primary endpoint in phase 2 trial
FrMedtronic taps TikTok-famous physician as first chief medical officer of GI business
FrBiotech founder, MIT researcher Sabatini alleges sexual harassment claims against him are false
FrMetacrine shares halved as NASH program nixed on mixed bag data and early safety issue
FrEgle Therapeutics nabs $46M as it looks to push into the clinic with next-gen Tregs platform
FrCould cancer drugs address a hard-to-treat lung disease? Researchers say 2 look promising
FrAgenus withdraws cervical cancer application, and a behind the scenes David vs. Big Pharma regulatory battle is revealed